Masoud Azodi, MD

Emeritus Faculty

DownloadHi-Res Photo

Contact Info

Obstetrics, Gynecology & Reproductive Sciences

PO Box 208063

New Haven, CT 06520-8063

United States

About

Titles

Emeritus Faculty

Biography

Dr. Azodi completed his undergraduate, graduate, medical school and Ob/Gyn residency training in Ohio. He then completed his fellowship in Gynecologic Oncology at Yale School of Medicine (YSM) in 1996.

Last Updated on January 16, 2026.

Departments & Organizations

All Institutions

Education & Training

Fellowship: Yale University School of Medicine (1999)

Residency: Aultman Hospital/Neoucom (1996)

MD: Wright State University (1992)

Research

Overview

Please see PubMed for publications.

Medical Research Interests

Biomarkers, Pharmacological; Cerclage, Cervical; Early Detection of Cancer; Fertility Preservation; Hereditary Breast and Ovarian Cancer Syndrome; Laparoscopy; Medical Oncology; Sarcoma, Endometrial Stromal

ORCID
0000-0002-0570-8089

Research at a Glance

Yale Co-Authors

Frequent collaborators of Masoud Azodi's published research.

Publications

2025

A PHASE II EVALUATION OF THE EFFICACY AND SAFETY OF SACITUZUMAB GOVITECAN IN PATIENTS WITH RECURRENT UTERINE CANCER
Santin A, Roque D, Siegel E, Ettorre V, Greenman M, Mcnamara B, Papatla K, Kailasam A, Azodi M, Buza N, Clark M, Hui P, Altwerger G, Dottino P, Ratner E, Bellone S. A PHASE II EVALUATION OF THE EFFICACY AND SAFETY OF SACITUZUMAB GOVITECAN IN PATIENTS WITH RECURRENT UTERINE CANCER. International Journal Of Gynecological Cancer 2025, 35: 102143. DOI: 10.1016/j.ijgc.2025.102143.
Peer-Reviewed Original Research
Concepts
Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer case
Abozenah Y, McNamara B, Greenman M, Daigle E, Mikhaiel J, DiCapua D, Kwan J, Azodi M, Altwerger G. Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer case. Gynecologic Oncology Reports 2025, 61: 101950. PMID: 41169950, PMCID: PMC12570088, DOI: 10.1016/j.gore.2025.101950.
Peer-Reviewed Original Research
Concepts
In vitro and in vivo activity of datopotamab deruxtecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in uterine and ovarian carcinosarcoma
Greenman M, Hartwich T, Demirkiran C, Bellone S, McNamara B, Yang Y, Altwerger G, Ratner E, Clark M, Papatla K, Azodi M, Dottino P, Schwartz P, Santin A. In vitro and in vivo activity of datopotamab deruxtecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in uterine and ovarian carcinosarcoma. Gynecologic Oncology 2025, 200: 318. DOI: 10.1016/j.ygyno.2025.04.452.
Peer-Reviewed Original Research
Concepts
Datopotamab deruxtecan, a TROP2-directed antibody-drug conjugate, demonstrates antitumor activity in uterine serous carcinoma
Greenman M, Demirkiran C, Bellone S, Ettorre V, Hartwich T, McNamara B, Yang Y, Altwerger G, Ratner E, Clark M, Papatla K, Azodi M, Dottino P, Schwartz P, Santin A. Datopotamab deruxtecan, a TROP2-directed antibody-drug conjugate, demonstrates antitumor activity in uterine serous carcinoma. Gynecologic Oncology 2025, 200: 204. DOI: 10.1016/j.ygyno.2025.04.263.
Peer-Reviewed Original Research
Concepts
Role of systematic lymphadenectomy at the time of cytoreductive surgery among non-high grade serous epithelial ovarian cancers
Greenman M, Demirkiran C, McNamara B, Altwerger G, Ratner E, Santin A, Papatla K, Dottino P, Azodi M, Schwartz P, Clark M. Role of systematic lymphadenectomy at the time of cytoreductive surgery among non-high grade serous epithelial ovarian cancers. Gynecologic Oncology 2025, 200: 239-240. DOI: 10.1016/j.ygyno.2025.04.320.
Peer-Reviewed Original Research
Concepts
Retrospective analysis of lenvatinib and pembrolizumab in endometrial cancer: Efficacy by tumor characteristics, platinum status and lenvatinib dose
Abozenah Y, Dzienny A, Yamartino K, Pan E, Vlamis C, Azodi M, Ratner E, Santin A, Clark M, Papatla K, Schwartz P, Altwerger G. Retrospective analysis of lenvatinib and pembrolizumab in endometrial cancer: Efficacy by tumor characteristics, platinum status and lenvatinib dose. Gynecologic Oncology 2025, 200: 202. DOI: 10.1016/j.ygyno.2025.04.260.
Peer-Reviewed Original Research
Concepts
Fertility preserving, uterine sparing approach to a uterine extragonadal yolk sac tumor
Greenman M, McNamara B, Ettorre V, Buza N, Azodi M. Fertility preserving, uterine sparing approach to a uterine extragonadal yolk sac tumor. Gynecologic Oncology Reports 2025, 59: 101778. PMID: 40585380, PMCID: PMC12205314, DOI: 10.1016/j.gore.2025.101778.
Peer-Reviewed Original Research
Concepts
The Multidisciplinary Management of a Patient With Infected Iliocaval Stents and Uterine Cancer Invasion
Said S, Gu E, Li A, Loh S, Mojibian H, Azodi M, Chaar C. The Multidisciplinary Management of a Patient With Infected Iliocaval Stents and Uterine Cancer Invasion. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2025, 13: 102135. DOI: 10.1016/j.jvsv.2024.102135.
Peer-Reviewed Original Research
Concepts
Vascular segmental exclusion for recurrent vulvar squamous cell carcinoma invading the femoral vessels
Schwartz A, Azodi M, Cardella J, Chaar C. Vascular segmental exclusion for recurrent vulvar squamous cell carcinoma invading the femoral vessels. Journal Of Vascular Surgery Cases And Innovative Techniques 2025, 11: 101753. PMID: 40207260, PMCID: PMC11981742, DOI: 10.1016/j.jvscit.2025.101753.
Peer-Reviewed Original Research
Concepts

See All Publications

Academic Achievements & Community Involvement

News & Links

Media

News

See All News

Get In Touch

Contacts

Mailing Address

Obstetrics, Gynecology & Reproductive Sciences

PO Box 208063

New Haven, CT 06520-8063

United States

Administrative Support

Meredith Baselice
Sr. Administrative Assistant

Locations

Yale Obstetrics, Gynecology & Reproductive Sciences
Academic Office
Farnam Memorial Building
310 Cedar Street, Wing Gynecologic Oncology, Fl 3rd, Ste 328E
New Haven, CT 06510
General Information
203.785.4013
Fax
203.785.4135
Get Directions

Contact Info

Titles

Biography

Departments & Organizations

Education & Training

Overview

Medical Research Interests

ORCID

Research at a Glance

Yale Co-Authors

Alessandro Santin, MD

Pei Hui, PhD, MD

Gloria Huang, MD, FACOG

Mitchell Clark, MD, MPH

Stefania Bellone, PhD

Elena Ratner, MD, MBA

Publications

2026

2025

Media

Masoud Azodi, MD[1]

News

16 Yale Ob/Gyn Physicians Named "Top Doctors" for 2025

Yale Ob/Gyn Faculty Present the Latest in Gynecologic Oncology at Memorial Conference

15 Yale Ob/Gyn Physicians Named "Top Doctors" For 2024

Genetic Analysis of Rare, Often Deadly Cervical Cancer Uncovers Potential Treatments

Contacts

Administrative Support

Locations

Yale Obstetrics, Gynecology & Reproductive Sciences